Innovative partnership will deliver expedited access to cancer treatment for New Brunswick patients

In New Brunswick, Horizon Health Network and Amgen Canada have agreed to work on establishing a new pathway that will see therapy made available to patients much faster than through conventional processes. The agreement will provide the Regional Health Authority with direct access to therapy, running parallel to the existing process, while dramatically reducing the amount of time the patient needs to wait for access to innovative treatment.

Read the full press release here.

Previous
Previous

Canada’s Health Researchers Suggest Key Panel Report as Summer Reading for MPs

Next
Next

Is Canada ready? Routine use of genome based testing in Canada's Major Regions. A State of Readiness Progress Report